Melanesia Experiences in Marine Drug Discovery at University of the South Pacific” Prof. B....
-
Upload
nick-ufford -
Category
Documents
-
view
214 -
download
0
Transcript of Melanesia Experiences in Marine Drug Discovery at University of the South Pacific” Prof. B....
Melanesia Experiences in Marine Drug Discovery at University of
the South Pacific”
Prof. B. Aalbersberg and K.-D. Feussner
CDDC, IAS, USP
Bioprospecting - Background
• 25-50% of western medicines are derived from natural sources (e.g. aspirin, quinine, many anti-cancer agents and anti biotic drugs)
• Sales near $800 billion• Process takes 15–20 years and costs $800 million• 1 in 10,000 chance to develop medicine from given
organism
Bioprospecting Process - 1
1. Permitting
2. Collecting
3. Extraction
4. Bioactivity Testing
5. Fractionation and Purification
6. Structure elucidation
Bioprospecting Process - 2
7. Organism Identification and Recollection
8. Structure – Activity Relationships
9. Toxicology Tests
10. Clinical Trials
11. Pray
Microbial Bioprospecting
1. Plating substrate
2. Colony Isolation and Purification
3. Fermentation
4. Extraction of Ferment
5. As in macroorganisms
Genetic Material
• DNA can be extracted, amplified and sequenced• Sections of genome that are responsible for various
functions (diseases, chemical production) can be identified
Work at USP
1. Permitting
2. Collecting
3. Extraction
4. Bioactivity Testing
5. Fractionation and Purification
6. Structure elucidation
Convention on Biological Diversity and Access and Benefit Sharing• Prior informed consent• Fair agreement on mutually agreed terms• Participation and sharing of benefits• Environmentally sound uses
Types of Benefits
• Cash (sample fee and royalties)• Help in resource management• Voucher specimen• Legal review• Participation in work and capacity building• Sharing results• Transfer of technology• Access to biotech outcomes
ABS and Fiji
• 1995 Verata Project• Full policy under the Sustainable Development Bill
(1997?)• Ad-hoc policies of Forestry (terrestrial) and Fisheries
(marine)• Interest of AG’s office• Availability from CBD Secretariat of Model
Provisions
USP Marine Collaborations
• 1980s UC Santa Cruz (Fiji)• 1990s Utah University (Fiji and Van.),
Strathclyde (Verata project)• 2000s Georgia Tech (Fiji), PharmaMar• 2010s Georgia Tech, CRRF (USNIH) (SI),• 2015 Nagoya Fund (SI)
Bioactivity Screens
1. Antimicrobial (fungi + bacteria – resistant strains)
2. Anti – cancer test• brine shrimp• cell lines• mechanism based
3. Others possible, e.g. malaria, dengue, Alzheimer, TB, anti-ageing